Non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in living-donor liver transplantation (LDLTX)

被引：0
|
作者：
Yamamoto, K [1 ]
Takada, Y [1 ]
Fujimoto, Y [1 ]
Haga, H [1 ]
Egawa, H [1 ]
Tanaka, K [1 ]
机构：
[1] Kyoto Univ, Dept Transplanta & Immunol, Kyoto, Japan
来源：
LIVER TRANSPLANTATION | 2004年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
116
引用
收藏
页码：C29 / C29
页数：1
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [2] Recurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Following Liver Transplantation for NASH Cirrhosis
    Matsuoka, Lea
    Slaughter, James
    Campbell, Kathyrn
    Kerr, Ashlie
    Hamel, Stephanie
    Garza, Carissa
    Chotai, Pranit
    Alexopoulos, Sophoclis
    Scanga, Andrew
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 15 - 15
  • [3] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [4] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [5] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [6] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
    South, K
    GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
  • [7] Non-alcoholic fatty liver disease (NAFLD) recurrence after liver transplant (OLT) for non-alcoholic steatohepatitis(NASH)
    Kawamura, Norio
    Nazzal, Mustafa
    El-Gazzaz, Galal
    Spaggiari, Mario
    Fujiki, Masato
    Diago, Teresa
    Aucejo, Federico N.
    Hashimoto, Koji
    Quintini, Cristiano
    Winans, Charles
    Eghtesad, Bijan
    Miller, Charles M.
    Fung, John J.
    Alkhouri, Naim
    Kelly, Dympna
    HEPATOLOGY, 2014, 60 : 617A - 617A
  • [8] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [9] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
    Cortez-Pinto, H
    Camilo, ME
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
  • [10] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Klein, Thomas
    Mark, Michael
    DIABETES, 2012, 61 : A265 - A266
12345